This study will test whether a personalized mobile application that provides temperature-related health risk warnings and protective recommendations can reduce acute exacerbations in people with chronic obstructive pulmonary disease (COPD). Researchers will compare participants who receive the mobile application in addition to usual care with those who receive usual care alone. The main question is whether the mobile application reduces the number of COPD acute exacerbation events over 12 months. The study will also evaluate secondary outcomes including quality of life, functional capacity, symptoms, psychological status, physiological and biochemical indicators, environmental temperature risk perception, and participants' use of the mobile application.
Tertiary hospitals;
Hospitals with respiratory wards that admit patients with COPD;
Hospitals with a well-established electronic health record system and follow-up capability;
Hospitals able to assign a study coordinator.
Primary hospitals or private hospitals;
Hospitals unable to cooperate with the study protocol.
Patients with asthma;
Women who are known to be pregnant or breastfeeding, or who have a positive pregnancy test before cluster randomization;
Parallel
Mobile Application-Based Personalized Temperature Health Risk Early Warning Intervention
Other interventionThis study implements a digital early warning intervention targeting personalized temperature-related health risks. The mobile application integrates real-time meteorological data and individual characteristics to generate risk levels and deliver tailored health alerts and guidance aimed at supporting risk management and reducing exposure-related health risks.
Number of COPD Acute Exacerbations
Total number of acute exacerbations of COPD managed at home, via outpatient visits, emergency department visits, or hospitalizations.
Number of Home-managed COPD Acute Exacerbations
Number of home-managed COPD acute exacerbations
Number of Outpatient-managed COPD Acute Exacerbations
Number of outpatient-managed COPD acute exacerbations
Number of Emergency Department-managed COPD Acute Exacerbations
Number of emergency department-managed COPD acute exacerbations
Number of Hospitalized COPD Acute Exacerbations
Number of hospitalized COPD acute exacerbations
Click on the lead sponsor to view all of their trials.
Tiantian Li
Lead sponsor
Centers for Disease Control and Prevention, China
Sponsor institution
This trial is not recruiting at the moment. You can still explore other options:
